Markov Models in Medical Decision Making: A Practical Guide
Abstract
Markov models are useful when a decision problem involves risk that is continuous over time, when the timing of events is important, and when important events may happen more than once. Representing such clinical settings with conventional decision trees is difficult and may require unrealistic simplifying assumptions. Markov models assume that a patient is always in one of a finite number of discrete health states, called Markov states. All events are represented as transitions from one state to another. A Markov model may be evaluated by matrix algebra, as a cohort simulation, or as a Monte Carlo simulation. A newer representation of Markov models, the Markov-cycle tree, uses a tree representation of clinical events and may be evaluated either as a cohort simulation or as a Monte Carlo simulation. The ability of the Markov model to represent repetitive events and the time dependence of both probabilities and utilities allows for more accurate representation of clinical settings that involve these issues.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cohort and individual-based state-transition frameworks focused on in this report do not capture interactions, model a single closed cohort, and allow transitions to occur only at specified time intervals.
“These frameworks do not capture interactions, model a single (closed) cohort, and allow transitions to occur only at specified time intervals.”
From State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012) · cites this paper as [8]
Giving a full reward at the start (i.e., transitions occur at cycle end) overestimates expected values; assigning no reward (i.e., transitions occur at cycle start) underestimates them.
“Giving a full reward at the start (i.e., transitions occur at cycle end) overestimates expected values; assigning no reward (i.e., transitions occur at cycle start) underestimates them [8].”
From State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3 (2012) · cites this paper as [8]
Cites
Gompertz, B. (1825) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1825.0026 · Cited by 3,816 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A systematic review and economic evaluation of statins for the prevention of coronary events
Ward, S., Lloyd Jones, M., Pandor, A., Holmes, M., Ara, R., Ryan, A., Yeo, W., & Payne, N. (2007) · Health Technology Assessment · doi:10.3310/hta11140 · Cited by 556 · see citing works
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.014 · Cited by 495 · see citing works
Myers, E. R., McCrory, D. C., Nanda, K., Bastian, L., & Matchar, D. B. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010166 · Cited by 470 · see citing works
Cost-effective osteoporosis treatment thresholds: the United States perspective
Tosteson, A. N. A., Melton, L. J., Dawson-Hughes, B., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0550-6 · Cited by 441 · see citing works
Sarasin, F. P., Giostra, E., & Hadengue, A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00197-0 · Cited by 368 · see citing works
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3
Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M. (2012) · Medical Decision Making · doi:10.1177/0272989x12455463 · Cited by 348 · see citing works
Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide
Stahl, J. E. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00004 · Cited by 171 · see citing works
Hutchins, V., Zhang, B., Fleurence, R. L., Krishnarajah, G., & Graham, J. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.570745 · Cited by 164 · see citing works
Meta-analysis of rare and adverse event data
Sutton, A. J., Cooper, N. J., Lambert, P. C., Jones, D. R., Abrams, K. R., & Sweeting, M. J. (2002) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2.4.367 · Cited by 141 · see citing works
Palmer, A. J., Roze, S., Valentine, W. J., Spinas, G. A., Shaw, J. E., & Zimmet, P. Z. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90029-x · Cited by 128 · see citing works
Echocardiography in patients with suspected endocarditis: a cost-effectiveness analysis
Heidenreich, P. A., Masoudi, F. A., Maini, B., Chou, T. M., Foster, E., Schiller, N. B., & Owens, D. K. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00216-8 · Cited by 119 · see citing works
Health Big Data Analytics: A Technology Survey
Harerimana, G., Jang, B., Kim, J. W., & Park, H. K. (2018) · IEEE Access · doi:10.1109/access.2018.2878254 · Cited by 119 · see citing works
Vitamin K to prevent fractures in older women: systematic review and economic evaluation
Stevenson, M., Lloyd-Jones, M., & Papaioannou, D. (2009) · Health Technology Assessment · doi:10.3310/hta13450 · Cited by 90 · see citing works
Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia
Cheng, C. H. F., Sanders, G. D., Hlatky, M. A., Heidenreich, P., McDonald, K. M., Lee, B. K., Larson, M. S., & Owens, D. K. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-11-200012050-00010 · Cited by 87 · see citing works
Eldridge, S., Spencer, A., Cryer, C., Parsons, S., Underwood, M., & Feder, G. (2005) · Journal of Health Services Research & Policy · doi:10.1258/1355819054338942 · Cited by 58 · see citing works
Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00074-3 · Cited by 44 · see citing works
Ruof, J., Golay, A., Berne, C., Collin, C., Lentz, J., & Maetzel, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802925 · Cited by 40 · see citing works
Alarid-Escudero, F., Krijkamp, E., Enns, E. A., Yang, A., Hunink, M. G. M., Pechlivanoglou, P., & Jalal, H. (2023) · Medical Decision Making · doi:10.1177/0272989x221103163 · Cited by 39 · see citing works
Denchev, P., Kaltman, J. R., Schoenbaum, M., & Vitiello, B. (2010) · Circulation · doi:10.1161/circulationaha.109.901256 · Cited by 38 · see citing works
Oral anticoagulation strategies after a first idiopathic venous thromboembolic event
Aujesky, D., Smith, K. J., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.02.018 · Cited by 29 · see citing works
Sankar, A., Dixon, P. R., Sivanathan, L., Memtsoudis, S. G., de Almeida, J. R., & Singh, M. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003429 · Cited by 22 · see citing works
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
Flam-Ross, J. M., Marsh, E., Weitz, M., Savinkina, A., Schackman, B. R., Wang, J., Madushani, R. W. M. A., Morgan, J. R., Barocas, J. A., Walley, A. Y., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.29583 · Cited by 21 · see citing works
Coleman, C. I., Limone, B. L., Bookhart, B. K., Mody, S. H., & Nutescu, E. A. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.006 · Cited by 18 · see citing works
McManus, E. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00487-6 · Cited by 10 · see citing works
- Authors
- Sonnenberg, F. A., & Beck, J. R.
- Venue
- Medical Decision Making
- Publisher
- SAGE Publications
- Published
- 1993-12
- Volume
- 13
- Issue
- 4
- Pages
- 322-338
- ISSN
- 0272-989X (ISSN-L)
- 1552-681X
- OpenAlex
- W2164654252
- Cited by
- 2,419
- References
- 1
- Citations by year
- 2026: 60 · 2025: 46 · 2024: 50 · 2023: 47 · 2022: 85 · 2021: 86 · 2020: 90 · 2019: 69 · 2018: 89 · 2017: 76 · 2016: 87 · 2015: 97 · 2014: 96 · 2013: 124 · 2012: 91
- FWCI
- 48.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Decision Making (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (5r29lm005266-05)
- Agency for Healthcare Research and Quality (HS06396)
- U.S. National Library of Medicine (LM05266)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Social Sciences › Decision Sciences › Management Science and Operations Research › Simulation Techniques and Applications
- Keywords
- Markov model, health states, state transitions, cohort simulation, Monte Carlo simulation, time-dependent probabilities, decision tree
- MeSH terms
- Adult, Anticoagulants, Decision Support Techniques, Embolism, Heart Valve Prosthesis, Hemorrhage, Humans, Male, Markov Chains, Monte Carlo Method, Postoperative Complications, Prognosis, Quality of Life, Cohort Studies, Survival Rate, Kidney Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review